Page last updated: 2024-12-11

androstane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

androstane: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6857536
CHEBI ID35509
MeSH IDM0104973

Synonyms (10)

Synonym
1h-cyclopenta[a]phenanthrene, hexadecahydro-10,13-dimethyl-, [8s-(8.alpha.,9.beta.,10.alpha.,13.alpha.,14.beta.)]-
androstane
CHEBI:35509
24887-75-0
androstane (van)
(8s-(8alpha,9beta,10alpha,13alpha,14beta))-hexadecahydro-10,13-dimethyl-1h-cyclopenta(a)phenanthrene
1h-cyclopenta(a)phenanthrene, hexadecahydro-10,13-dimethyl-, (8s-(8alpha,9beta,10alpha,13alpha,14beta))-
QZLYKIGBANMMBK-FZFXZXLVSA-N
DTXSID40179587
Q2846975

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Our preliminary study has suggested that musk ingestion did not lead to AAFs of doping control with the single dosage of 100 mg."( Steroid profile and IRMS analysis of musk administration for doping control.
He, Y; Liu, X; Wang, J; Yang, W; Yang, Z, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
steroid fundamental parent
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (85)

TimeframeStudies, This Drug (%)All Drugs %
pre-199037 (43.53)18.7374
1990's5 (5.88)18.2507
2000's19 (22.35)29.6817
2010's22 (25.88)24.3611
2020's2 (2.35)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.39 (24.57)
Research Supply Index4.51 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index57.12 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (39.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other89 (98.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]